• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服复方新诺明在全科医疗中治疗外耳道炎的疗效。

The efficacy of oral cotrimoxazole in the treatment of otitis externa in general practice.

作者信息

Yelland M J

机构信息

Department of Social and Preventive Medicine, University of Queensland, Inala.

出版信息

Med J Aust. 1993 May 17;158(10):697-9. doi: 10.5694/j.1326-5377.1993.tb121918.x.

DOI:10.5694/j.1326-5377.1993.tb121918.x
PMID:7683742
Abstract

AIM

A double-blind, randomised clinical trial was conducted in Queensland general practices to evaluate the efficacy of oral doses of trimethoprim-sulfamethoxazole (cotrimoxazole) as an adjunct to Kenacomb ointment in the treatment of acute diffuse otitis externa.

METHOD

One hundred and five patients with otitis externa agreed to enter the trial; 13 of these had bilateral otitis externa. Six symptoms and signs of otitis externa were rated on a scale of 1 (none) to 5 (severe) and then the scores were averaged to give an index of severity. Swabs from all infected ears were cultured and then the patients were treated with Kenacomb ointment. Patients were randomly assigned to take a five-day course of either oral cotrimoxazole or an oral placebo and were reassessed on Days 2-4 and Days 5-6 after presentation.

RESULTS

The mean duration (+/- standard deviation) of ear pain from the first visit for the cotrimoxazole and placebo groups was 3.1 (+/- 1.5) days and 3.1 (+/- 1.7) days respectively. The mean severity indices (+/- standard deviation) for these groups on presentation were 2.33 (+/- 0.59) and 2.37 (+/- 0.57). The respective reductions in these scores by the second visit were 0.72 and 0.69 and by the third visit 1.10 and 1.05. The principle pathogen isolated was Pseudomonas aeruginosa.

CONCLUSION

This suggests that oral cotrimoxazole is unlikely to be useful as an adjunct to Kenacomb ointment in the treatment of mild to moderate otitis externa.

摘要

目的

在昆士兰州的普通诊所进行了一项双盲随机临床试验,以评估口服甲氧苄啶 - 磺胺甲恶唑(复方新诺明)作为辅助肯纳康软膏治疗急性弥漫性外耳道炎的疗效。

方法

105例外耳道炎患者同意参加试验;其中13例为双侧外耳道炎。对外耳道炎的六种症状和体征按1(无)至5(严重)进行评分,然后将分数平均得出严重程度指数。对所有感染耳朵进行拭子培养,然后用肯纳康软膏治疗患者。患者被随机分配接受为期五天的口服复方新诺明或口服安慰剂疗程,并在就诊后的第2 - 4天和第5 - 6天进行重新评估。

结果

复方新诺明组和安慰剂组首次就诊时耳痛的平均持续时间(±标准差)分别为3.1(±1.5)天和3.1(±1.7)天。这些组就诊时的平均严重程度指数(±标准差)分别为2.33(±0.59)和2.37(±0.57)。第二次就诊时这些分数的相应降低分别为0.72和0.69,第三次就诊时分别为1.10和1.05。分离出的主要病原体是铜绿假单胞菌。

结论

这表明口服复方新诺明作为辅助肯纳康软膏治疗轻度至中度外耳道炎不太可能有用。

相似文献

1
The efficacy of oral cotrimoxazole in the treatment of otitis externa in general practice.口服复方新诺明在全科医疗中治疗外耳道炎的疗效。
Med J Aust. 1993 May 17;158(10):697-9. doi: 10.5694/j.1326-5377.1993.tb121918.x.
2
A randomised controlled trial comparing Triadcortyl with 10% glycerine-ichthammol in the initial treatment of severe acute otitis externa.一项比较曲安奈德与10%甘油鱼石脂在重度急性外耳道炎初始治疗中疗效的随机对照试验。
Eur Arch Otorhinolaryngol. 2008 Aug;265(8):881-5. doi: 10.1007/s00405-007-0463-1. Epub 2007 Oct 6.
3
An alternative to regular dressings for otitis externa and chronic supperative otitis media?
J Laryngol Otol. 1995 Feb;109(2):101-3. doi: 10.1017/s0022215100129391.
4
Use of trimethoprim-sulfamethoxazole in external otitis.甲氧苄啶-磺胺甲恶唑在外耳道炎中的应用。
Can Med Assoc J. 1975 Jun 14;112(13 Spec No):82-3.
5
Clinical efficacy of three common treatments in acute otitis externa in primary care: randomised controlled trial.基层医疗中三种常见疗法治疗急性外耳道炎的临床疗效:随机对照试验
BMJ. 2003 Nov 22;327(7425):1201-5. doi: 10.1136/bmj.327.7425.1201.
6
A general practice study to compare the efficacy and tolerability of a spray ('Otomize') versus a standard drop formulation ('Sofradex') in the treatment of patients with otitis externa.
Curr Med Res Opin. 1990;12(1):12-8. doi: 10.1185/03007999009111486.
7
Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.每日一次的氧氟沙星耳用溶液与每日四次的硫酸新霉素/硫酸多粘菌素B/氢化可的松耳用混悬液对比:一项多中心、随机、评估者盲法试验,比较小儿外耳道炎患者的疗效、安全性及疼痛缓解情况。
Curr Med Res Opin. 2006 Sep;22(9):1725-36. doi: 10.1185/030079906X121057.
8
Treatment patterns for otitis externa.外耳道炎的治疗模式。
J Am Board Fam Pract. 1999 Jan-Feb;12(1):1-7. doi: 10.3122/15572625-12-1-1.
9
Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.两项临床试验的汇总分析,比较了环丙沙星/地塞米松耳用混悬液与多粘菌素B/新霉素/氢化可的松耳用混悬液治疗成人和儿童急性外耳道炎的临床疗效。
Clin Ther. 2007 Sep;29(9):1950-6. doi: 10.1016/j.clinthera.2007.09.005.
10
A double-blind randomised clinical trial of the treatment of otitis externa using topical steroid alone versus topical steroid-antibiotic therapy.一项关于单纯外用类固醇与外用类固醇 - 抗生素疗法治疗外耳道炎的双盲随机临床试验。
Eur Arch Otorhinolaryngol. 2009 Jan;266(1):41-5. doi: 10.1007/s00405-008-0712-y. Epub 2008 Jun 17.

引用本文的文献

1
Otitis externa.外耳道炎
BMJ Clin Evid. 2015 Jun 15;2015:0510.
2
Acute otitis externa in children.儿童急性外耳炎。
Can Fam Physician. 2012 Nov;58(11):1222-4.
3
Otitis externa.外耳道炎
BMJ Clin Evid. 2010 Aug 3;2010:0510.
4
Otitis externa.外耳道炎
BMJ Clin Evid. 2008 Jun 26;2008:0510.